Hereditary disorders of connective tissue: A review

Wound Repair and Regeneration

Volumn 5, Issue 1, 1997, Pages 3-11

  Klett, Carrie C ^a,b   Diegelmann, Robert F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18144410967     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.1997.50105.x     Document Type: Review

References (38)

1. Prockop DJ, Kivirikko KI. Collagens: molecular biology, diseases, and potentials for therapy. Ann Rev Biochem 1995;64:403-34.
2. Bonadio J, Holbrook KA, Gelinas RE, Jacob J, Byers PH. Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem 1985;260:1734-42.
3. McKusick VA. Heritable disorders of connective tissue. 4th edition. St. Louis: Mosby, 1972.
4. Vuorio E, de Crombrugghe B. The family of collagen genes. Annu Rev Biochem 1990;59:837-72.
5. Karsenty G, Ravazzolo R, de Crombrugghe B. Purification and functional characterization of a DNA-binding protein that interacts with a negative element in the mouse α1 (I) collagen promoter. J Biol Chem 1991;266:24842-8.
6. Routeshouser EC, de Crombrugghe B. Purification of BBF, a DNA-binding protein recognizing a positive cis-acting element in the mouse α1 (III) promoter. J Biol Chem 1992;267:14398-404.
7. Maity SN, Sinha S, Routeshouser EC, de Crombrugghe B. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem 1992;267:16574-80.
8. Goldberg H, Helaakoski T, Garrett LA, Karsenty G, Pellegrino A, Lozano G, Maity S, de Crombrugghe B. Tissue-specific expression of the mouse α2 (I) collagen promoter. J Biol Chem 1992;267:19622-30.
9. Prockop DJ, Kivirikko KI. Heritable diseases of collagen. N Engl J Med 1984;311:376-86.
10. Kivirikko KI, Myllyla R. Post-translational modifications. In: Weiss JB, Jayson MIV, editors. Collagen in health and disease. Edinburgh: Churchill Livingstone, 1982:101-20.
11. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA. The biosynthesis of collagen and its disorders. N Engl J Med 1979;301: 13-23,77-85.
12. Heathcote JC, Grant ME. Extracellular modification of connective tissue proteins. In: Freedman RB, Hawkins HC, editors. The enzymology of post-translational modifications of proteins. London: Academic Press, 1980:457-506.
13. Prockop DJ, Berg RA, Kivirikko KI. Intracellular steps in the biosynthesis of collagen. In: Ramachadran GN, Reddi AH, editors. Biochemistry of collagen. New York: Plenum Press, 1976: 163-273.
14. Kivirikko KI, Myllyla R. Post-translational enzymes in the biosynthesis of collagen. Meth Enzymol 1982;82A:245-304.
15. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA. Osteogenesis imperfecta: phenotypic heterogeneity, protein suicide, short and long collagen. Am J Hum Genet 1984;36:499-505.
16. Prockop DJ, Colige A, Helminen H, Khillan JS, Pereira R, Vandenberg P. Mutations in type I procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies. J Bone Miner Res 1993;8(Suppl 2):S489-92.
17. Prockop DJ, Kuivaniemi H, Tromp G. Molecular basis of osteogenesis imperfecta and related disorders of bone. Clin Plast Surg 1994;21:407-13.
18. Sillence DO, Senn A, Damks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16:101-16.
19. Levin LS, Salinas CF, Jorgenson RJ. Classification of osteogenesis imperfecta by dental characteristics. Lancet 1978;1:332-3.
20. Byers PH, Osteogenesis imperfecta: an update. Growth Genet Hormones 1988;4:1-5.
21. Marini JC, Grange DK, Gottesman GS, Lewis MB, Koeplin DA. Osteogenesis imperfecta type IV: detection of a point mutation in one α1(I) collagen allele(COL1A1) by RNA/RNA hybrid analysis. J Biol Chem 1989;264:11893-900.
22. Marini JC. Osteogenesis imperfecta: comprehensive management. Adv Ped 1988;35:391-426.
23. Burnett HF, Bledsoe JH, Char FC. Abdominal aortic aneurysmectomy in a 17 year old patient with Ehlers-Danlos syndrome: case report and review of the literature. Surgery 1973;74: 617-20.
24. Kashiwagi H, Riddle JM, Abraham JP. Functional and ultrastructural abnormalities of platelets in Ehrlers-Danlos syndrome. Ann Int Med 1965;63:249-54.
25. Wesley JR, Mahour GH, Woolley MM. Multiple surgical problems in two patients with Ehlers-Danlos syndrome. Surgery 1980;87:319-24.
26. McKusick VA. Multiple forms of Ehlers Danlos syndrome. Arch Surg 1974;109:475-6.
27. McKusick VA. The defect in Marfan syndrome. Nature 1991;353: 279-81.
28. Lee B, Godfrey M, Vitale E, Hori H, Mattei MG, Sarfarazi M, Isicouras P, Ramirez F, Hollister DW. Linkage of Marfan syndrome and a phenotypically related disorder of two different fibrillin genes. Nature 1991;353:330-4.
29. Dietz HC, Pyeritz RE, Hall BD, Cadle RG, Hamosh A, Schwartz J, Meyers DA, Francomano CA. The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3. Genomics 1991;9: 355-61.
30. Kainulainer K, Pulkkinen L, Savolainen A, Kaitila I, Peltonen L. Location on chromosome 15 of the gene defect causing Marfan syndrome. N Engl J Med 1990;323:935-9.
31. Maslan CL, Corson GM, Maddox BK, Glanville RW, Sakai LY. Partial sequence of a candidate gene for the Marfan syndrome. Nature 1991;352:334-7.
32. Uitto J, Christiano AM. Inherited epidermolysis bullosa. Clinical features, molecular genetics, and pathoetiologic mechanisms. Dermatol Clin 1993;11:549-63.
33. Bauer EA, Gedde-Dahl T, Eisen AZ. The role of human skin collagenase in epidermolysis bullosa. J Invest Dermatol 1977;68: 119-24.
34. Uitto J, Hovnanian A, Christiano AM. Premature termination codon mutations in the type VII collagen gene (COL7A1) underlie severe recessive dystrophic epidermolysis bullosa. Proc Assoc Am Physicians 1995;107:245-52.
35. Uitto J, Christiano AM. Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene. Arch Dermatol Res 1994;287:16-22.
36. Christiano AM, Ryynanen M, Uitto J. Dominant dystrophic epidermolysis bullosa: identification of a Gly->Ser substitution in the triple-helical domain of type VII collagen. Proc Natl Acad Sci U S A 1994;91:3549-53.
37. McGrath JA, Gatalica B, Li K, Dunnill MG, McMillan JR, Christiano AM, Eady RA, Uitto J. Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol 1996;148:1727-31.
38. Fonkalsrud EW, Ament ME. Surgical management of esophageal stricture due to recessive dystrophic epidermolysis bullosa. J Pediatr Surg 1977;12:221-6.